Krsnaa Diagnostics Board Approves Director & CFO Appointments, Reconstitutes Committees

Krsnaa Diagnostics' Board of Directors, at its meeting on April 17, 2026, approved significant changes to its leadership and governance framework. Mr. Raju Venkatraman and Ms. Lilian Jessie Paul were appointed as Additional Independent Directors for two years, and Mr. Chetan Desai was re-appointed as an Independent Director for five years. Mr. Chandra Prakash Singh was appointed as Interim CFO. Concurrently, Ms. Pallavi Bhatevara ceased to be a Whole-time Director, and Mr. Rajiva Ranjan Verma and Ms. Chhaya Palrecha completed their tenures as Independent Directors. The Board also approved the reconstitution of key committees, including Audit, Nomination and Remuneration, Corporate Social Responsibility, Stakeholders Relationship, and Risk Management Committees, effective April 25, 2026. These changes aim to strengthen the company's board and committee leadership.